Type I interferons have been suspected for decades to have a crucial role in the pathogenesis of systemic lupus erythematosus (SLE). Evidence has now overturned several …
The past 20 years have seen the definition of human monogenic disorders and their autoimmune phenocopies underlying either defective or enhanced type I interferon (IFN) …
Since its discovery, the Janus kinase-signal transduction and activation of transcription (JAK- STAT) pathway has become recognized as a central mediator of widespread and varied …
AMS Giordano, M Luciani, F Gatto… - Journal of Experimental …, 2022 - rupress.org
Aberrant induction of type I IFN is a hallmark of the inherited encephalopathy Aicardi- Goutières syndrome (AGS), but the mechanisms triggering disease in the human central …
RP Agashe, SM Lippman, R Kurzrock - Molecular cancer therapeutics, 2022 - AACR
The JAK/STAT axis is implicated in cancer, inflammation, and immunity. Numerous cytokines/growth factors affect JAK/STAT signaling. JAKs (JAK1, JAK2, JAK3, and TYK 2) …
KC Gedik, L Lamot, M Romano, E Demirkaya… - Annals of the …, 2022 - ard.bmj.com
Objective Autoinflammatory type I interferonopathies, chronic atypical neutrophilic dermatosis with lipodystrophy and elevated temperature/proteasome-associated …
T Bieber, E Feist, AD Irvine, M Harigai, E Haladyj… - Advances in …, 2022 - Springer
Baricitinib is an oral, selective inhibitor of Janus kinase (JAK) 1/JAK2 that transiently and reversibly inhibits many proinflammatory cytokines. This mechanism is a key mediator in a …
W Damsky, D Peterson, J Ramseier… - Journal of Allergy and …, 2021 - Elsevier
Autoimmune and inflammatory diseases are common and diverse, and they can affect nearly any organ system. Much of the pathogenesis of these diseases is related to …